Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate (Q47896240)

6 February 2018

title

Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate (English)

1 reference

6 February 2018

0 references

1 reference

Milich DR

1

1 reference

6 February 2018

Hughes J

2

1 reference

6 February 2018

Jones J

3

1 reference

6 February 2018

Sällberg M

4

1 reference

6 February 2018

Phillips TR

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 December 2001

1 reference

6 February 2018

published in

Vaccine

1 reference

6 February 2018

volume

20

1 reference

6 February 2018

issue

5-6

1 reference

6 February 2018

page(s)

771-788

1 reference

6 February 2018

Pathways and strategies for developing a malaria blood-stage vaccine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Rationale for the development of an engineered sporozoite malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Sporozoite-induced immunity in mammalian malaria. A review.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Synthetic peptide vaccine confers protection against murine malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Rationale for development of a synthetic vaccine against plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Phase I Clinical Trial of a Recombinant Malaria Vaccine Consisting of the Circumsporozoite Repeat Region of Plasmodium Falciparum Coupled to Hepatitis B Surface Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

The hepatitis nucleocapsid as a vaccine carrier moiety

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Nondeletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Human T-cell recognition of the circumsporozoite protein of plasmodium falciparum: Immunodominant T-cell domains map to the polymorphic regions of the molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of theP. falciparum circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Rapid “tea-bag” peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Hepatitis B virus capsid particles are assembled from core-protein dimer precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Role of B cells in antigen presentation of the hepatitis B core

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Possible role of immune responses to hepatitis B core antigen in protection against hepatitis B infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

CD4+ cytolytic T cell clone confers protection against murine malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

The complexity of protective immunity against liver-stage malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Sterile protection of monkeys against malaria after administration of interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

Congenital transfer of antibodies against malarial sporozoites detected in Gambian infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900400-5

7 January 2021

10.1016/S0264-410X(01)00400-5

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018